These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26256265)

  • 1. Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.
    Bandara G; Beaven MA; Olivera A; Gilfillan AM; Metcalfe DD
    Eur J Immunol; 2015 Nov; 45(11):3034-44. PubMed ID: 26256265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells control lung type 2 inflammation via prostaglandin E
    Alhallak K; Nagai J; Zaleski K; Marshall S; Salloum T; Derakhshan T; Hayashi H; Feng C; Kratchmarov R; Lai J; Kuchibhotla V; Nishida A; Balestrieri B; Laidlaw T; Dwyer DF; Boyce JA
    Immunity; 2024 Jun; 57(6):1274-1288.e6. PubMed ID: 38821053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-33/ST2 axis: Role in health and disease.
    De la Fuente M; MacDonald TT; Hermoso MA
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons.
    He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J
    Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells.
    Allakhverdi Z; Smith DE; Comeau MR; Delespesse G
    J Immunol; 2007 Aug; 179(4):2051-4. PubMed ID: 17675461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-33/ST2 axis promotes mast cell survival via BCLXL.
    Wang JX; Kaieda S; Ameri S; Fishgal N; Dwyer D; Dellinger A; Kepley CL; Gurish MF; Nigrovic PA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10281-6. PubMed ID: 24982172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.
    Sweet MJ; Leung BP; Kang D; Sogaard M; Schulz K; Trajkovic V; Campbell CC; Xu D; Liew FY
    J Immunol; 2001 Jun; 166(11):6633-9. PubMed ID: 11359817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
    Takenaga K; Akimoto M; Koshikawa N; Nagase H
    PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory function of Fc-ST2 depends on cell type; IL-1RAcP and ST2 are necessary but insufficient for IL-33 activity.
    Hong K; Lee Y; Lee S; Hong S; Bae S; Hong J; Choi J; Jhun H; Kwak A; Kim E; Jo S; Kang T; Cho YS; Kim YG; Kim S
    Immunol Res; 2013 May; 56(1):122-30. PubMed ID: 23435764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-33 synergistically enhances immune complex-induced tumor necrosis factor alpha and interleukin-8 production in cultured human synovium-derived mast cells.
    Kashiwakura J; Yanagisawa M; Lee H; Okamura Y; Sasaki-Sakamoto T; Saito S; Tokuhashi Y; Ra C; Okayama Y
    Int Arch Allergy Immunol; 2013; 161 Suppl 2():32-6. PubMed ID: 23711851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ST2 suppresses IL-5 production by human basophilic KU812 cells, induced by epithelial cell-derived IL-33.
    Matsumoto K; Kouzaki H; Kikuoka H; Kato T; Tojima I; Shimizu S; Shimizu T
    Allergol Int; 2018 Sep; 67S():S32-S37. PubMed ID: 29941231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
    Hayakawa H; Hayakawa M; Kume A; Tominaga S
    J Biol Chem; 2007 Sep; 282(36):26369-80. PubMed ID: 17623648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-33 primes mast cells for activation by IgG immune complexes.
    Kaieda S; Wang JX; Shnayder R; Fishgal N; Hei H; Lee RT; Stevens RL; Nigrovic PA
    PLoS One; 2012; 7(10):e47252. PubMed ID: 23071771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
    Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
    J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells.
    Zhang Y; Zhang C; Zhuang R; Ma Y; Zhang Y; Yi J; Yang A; Jin B
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003514. PubMed ID: 25658420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma.
    Lee HY; Rhee CK; Kang JY; Byun JH; Choi JY; Kim SJ; Kim YK; Kwon SS; Lee SY
    Exp Lung Res; 2014 Mar; 40(2):66-76. PubMed ID: 24446582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
    Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
    J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62.
    Ball DH; Al-Riyami L; Harnett W; Harnett MM
    Sci Rep; 2018 Mar; 8(1):4497. PubMed ID: 29540770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.